Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04241120 · ClinicalTrials.gov registry record · NA
Feasibility Study for Treating Trichotillomania With Wearable Device and App System
A NA study of Trichotillomania, sponsored by HabitAware.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04241120: Completed NA study of Trichotillomania, sponsored by HabitAware.
NCT04241120 is a NA study of Trichotillomania that has completed, run by HabitAware. The registered enrollment target is 15 participants, below the 70-participant average among 8 other Trichotillomania trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04241120, a NA study of Trichotillomania, has completed, sponsored by HabitAware.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing significant distress and impairment which persists despite repeated attempts to stop. Behavioral based therapies focused on increasing awareness of hair pulling followed by the use of an incompatible behavior have proven effective. In an effort to enhance awareness, a wrist worn motion detection device was created. In this study, we will test the feasibility of the HabitAware device and accompanying app as a system for delivering self-administered habit reversal training (HRT).
Primary Outcome
Measured via post-treatment surveys.
Conditions Studied
Interventions
- BEHAVIORAL Device and app system designed for participant to self-administer Habit Reversal Training
- BEHAVIORAL Reminder bracelet control condition
Study Locations (1)
Minnesota
- HabitAware, Inc. - Saint Louis Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2020-03-04 |
| Phase | NA |
What the finished NCT04241120 record still lists
NCT04241120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 70-participant average among 8 other Trichotillomania trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 2 interventions - of which Device and app system designed for participant to self-administer Habit Reversal Training is the first listed.
NCT04241120 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04241120 about?
NCT04241120 is a clinical study titled "Feasibility Study for Treating Trichotillomania With Wearable Device and App System". Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing significant distress and impairment which persists despite repeated attempts to stop. Behavioral based therapies focused on increasing awareness of hair pulling followed by the use of an incompatible behavior ...
What is the current status of trial NCT04241120?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-01-16. Estimated completion is 2020-03-04.
What conditions does trial NCT04241120 study?
This clinical trial studies the following conditions: Trichotillomania.
What interventions are being tested in trial NCT04241120?
The interventions under investigation include: Device and app system designed for participant to self-administer Habit Reversal Training (BEHAVIORAL), Reminder bracelet control condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT04241120?
This trial is sponsored by HabitAware, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04241120 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trichotillomania
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04241120's enrollment target sits among peer trials
15 8th of 8 higher than 1 of 8 other Trichotillomania trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trichotillomania trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Technology Assisted Treatment of Trichotillomania: Open Trial
RECRUITING · NA
-
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
ACTIVE NOT RECRUITING · NA
-
Cognitive Behavioral Treatment of Pediatric Trichotillomania
COMPLETED · NA
-
Response Inhibition Training for Individuals With Trichotillomania
COMPLETED · NA
-
Habit Reversal Training for Children and Adolescents With Trichotillomania
COMPLETED · NA
-
N-Acetylcysteine for Pediatric Trichotillomania
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI